Personalized Medicine

Papers
(The H4-Index of Personalized Medicine is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
The role of circular RNAs in therapy resistance of patients with solid tumors35
A review of clinical pharmacogenetics Studies in African populations34
The evolution of personalized healthcare and the pivotal role of European regions in its implementation29
Assessment of healthcare professionals’ knowledge, attitudes, and perceived challenges of clinical pharmacogenetic testing in Egypt28
Microsatellite instability testing in colorectal patients with Lynch syndrome: lessons learned from a case report and how to avoid such pitfalls27
Review of policies of companies and databases regarding access to customers’ genealogy data for law enforcement purposes22
International consortium for personalized medicine: an international survey about the future of personalized medicine17
Elevated expression of ASF1B correlates with poor prognosis in human lung adenocarcinoma17
Increase inMEG3, MALAT1, NEAT1significantly predicts the clinical parameters in patients with rheumatoid arthritis14
The United States 2020 Census data: implications for precision medicine and the research landscape14
Pharmacogenomic considerations for repurposing of dexamethasone as a potential drug against SARS-CoV-2 infection13
Gout prevalence in the Hmong: a prime example of health disparity and the role of community-based genetic research12
Sorafenib treatment has the potential to downstage advanced hepatocellular carcinoma before liver resection12
0.021847009658813